IGF-DES 2mg

Quickstart Highlights

Reference-linked protocol details for IGF-DES 2mg.

Reference title: IGF-1 DES Dosing Protocols and Administration | Peptide Protocol Wiki
Product: IGF-DES 2mg vial
A high-caution growth-factor research entry for IGF signaling and glucose-risk review.
Source page: Open source

Protocol Overview

IGF-DES is a truncated IGF-1 analog that is generally described as having reduced binding to IGF-binding proteins and strong local IGF receptor activity in research settings. Because it directly engages growth-factor and glucose-related pathways, it should be handled as a high-caution research product requiring clinician review, glucose-risk screening, and no performance or treatment claims.

IGF signaling research context
Growth-factor safety review
Glucose-risk screening
High-caution clinician discussion

Recommended Source

This protocol is linked to the workbook reference source below.

IGF-1 DES Dosing Protocols and Administration | Peptide Protocol Wiki Open source

Dosing & Reconstitution Guide

Localized muscle growth and repair via potent IGF-1 receptor activation (research only)

Amount
20-100 mcg per injection (typically 50 mcg bilaterally into target muscles)
Frequency
Pre- or post-workout only; training days only
Duration
4 weeks on, 2-4 weeks off
Route
Schedule
Timing
Immediately post-workout (within 10-15 minutes) or 15-30 minutes pre-workout
Rest Period
4 weeks off between cycles
Repeatable
Yes
Diluent: Bacteriostatic water
Use within: Use immediately after reconstitution
Storage: Lyophilized powder: store at -20C or below, stable for months. Reconstituted solution: store at 4C for short-term use (up to 1 week) or aliquot and store at -20C to -80C for longer storage. Avoid repeated freeze-thaw cycles.
IGF-1
When: Baseline
Why: Baseline growth factor levels
Fasting glucose and fasting insulin
Why: IGF-1 DES can cause acute hypoglycemia
HbA1c
Why: Baseline glycemic marker
Fasting glucose
When: Weekly during first 2 weeks
Why: Monitor for hypoglycemia risk
When: 2-3 weeks
Why: Assess impact on systemic IGF-1 levels
Blood glucose
When: Ongoing
Why: Acute hypoglycemia risk (glucose <70 mg/dL); keep fast-acting carbs available
⚠️ Acute hypoglycemia risk (glucose <70 mg/dL); keep fast-acting carbs available
→Extremely short half-life (~5 minutes) makes it site-specific when injected locally
→Must be used immediately after reconstitution due to rapid degradation
→Localized IM injection into trained muscles is preferred to maximize site-specific effects
→Hypoglycemia is a real and dangerous risk; always have fast-acting carbohydrates available
→Contraindication: Avoid in active or history of cancer; contraindicated in hypoglycemia-prone individuals or those on insulin/sulfonylureas

Dosing Protocol

Free access to research-backed dosing information for all peptides.

Purpose	Dose	Frequency	Duration	Notes
Cell culture - proliferation assays	1-100 ng/mL in culture medium	Added at medium change or as single pulse	24-72 hours per experiment	Typical EC50 for proliferation in responsive cell lines is 1-10 ng/mL, approximately 10-fold lower than native IGF-1.
Cell culture - differentiation studies	10-100 ng/mL in culture medium	Added at medium changes throughout differentiation period	Variable, typically 5-14 days for myogenic differentiation	Higher concentrations often used for differentiation protocols. Replaced at each medium change due to degradation in conditioned media.
Preclinical research - local administration (animal models)	Research use only - doses vary by study design	Variable by protocol	Variable by study objectives	No standardized in vivo dosing protocols exist. Published animal studies have used a wide range of doses and routes. Not for human use.

150+ peptide profiles · 30+ comparisons · 18 research tools
Free access to complete dosing tables and protocol details.
Reconstitute lyophilized IGF-1 DES in sterile water, 0.1M acetic acid, or PBS at pH 7.4. Typical stock concentrations of 100-1000 micrograms/mL. Avoid repeated freeze-thaw cycles. Aliquot upon reconstitution.
Lyophilized powder: store at -20C or below, stable for months. Reconstituted solution: store at 4C for short-term use (up to 1 week) or aliquot and store at -20C to -80C for longer storage. Avoid repeated freeze-thaw cycles.
Compare these clinical doses with what 50+ community members report using.
Based on 50+ community reports
Review safety warnings and contraindications before starting any protocol.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Storage Conditions#

Form	Temperature	Expected Stability	Notes
Lyophilized powder	-20 to -80 degrees C	Months to years	Protect from moisture; desiccate
Reconstituted stock	4 degrees C	Up to 1 week	Short-term working stock only
Reconstituted aliquots	-20 to -80 degrees C	Weeks to months	Single-use aliquots preferred
In culture medium	37 degrees C	Hours	Degrades in conditioned media; replenish at medium changes

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References

Reference source used for this protocol page.

IGF-1 DES Dosing Protocols and Administration | Peptide Protocol Wiki Open source
Peptify Reconstitution Guide

Contents